Uncertainty and coping in patients with newly diagnosed indolent non-Hodgkin's lymphoma (iNHL)

被引：0
|
作者：
Newcomb, Richard
Johnson, Patrick Connor
Yang, Daniel
Amonoo, Hermioni L.
Dhawale, Tejaswini More
Chen, Yi-Bin Albert
El-Jawahri, Areej
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7568
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Indolent Non-Hodgkin's Lymphoma (iNHL)
    Sharman, Jeff P.
    Klein, Leonard M.
    Boxer, Michael
    Kolibaba, Kathryn S.
    Abella, Steve
    Eng, Clarence
    He, Jing
    Hu, Jing
    Yasenchak, Christopher A.
    BLOOD, 2015, 126 (23)
  • [32] Increasing treatment options in indolent non-Hodgkin's lymphoma
    Solal-Céligny, P
    SEMINARS IN ONCOLOGY, 2002, 29 (02) : 2 - 6
  • [33] Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma
    Zinzani, PL
    HEMATOLOGY JOURNAL, 2004, 5 : S38 - S49
  • [34] New treatment approaches to indolent non-Hodgkin's lymphoma
    Seymour, JF
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 27 - 32
  • [35] COST OF PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND INDOLENT NON-HODGKIN'S LYMPHOMA (INHL) IN THE UNITED KINGDOM (UK)
    Cognet, M.
    Druais, S.
    Gervais, F.
    Gauthier, A.
    Abrams, K. R.
    VALUE IN HEALTH, 2014, 17 (07) : A549 - A549
  • [36] Treatment of indolent non-hodgkin's lymphoma with liposomal doxorubicin
    Ponomarova, Olga V.
    Kavetsky, R. E.
    ANNALS OF ONCOLOGY, 2007, 18 : 182 - 182
  • [37] Current approaches to therapy for indolent non-Hodgkin's lymphoma
    Cheson, BD
    ONCOLOGY-NEW YORK, 1998, 12 (10): : 25 - 34
  • [38] Lenalidomide and rituximab for untreated indolent non-Hodgkin's lymphoma
    Fowler, N. H.
    McLaughlin, P.
    Kwak, L.
    Hagemeister, F.
    Fanale, M.
    Fayad, L.
    Pro, B.
    Samaniego, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Efficacy of 18F-FDG PET/CT in detection of bone marrow involvement in patients with newly diagnosed indolent Non-Hodgkin's Lymphoma
    Sandoval Moreno, C.
    Garcia Alonso, P.
    Tagliatori Nogueira, M.
    Mena Melgar, C.
    de la Rubia Marcos, M.
    Herrero Munoz, A.
    Paniagua Correa, C.
    Castillejos Rodriguez, L.
    Ortega Valle, A.
    Balsa Breton, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S562 - S562
  • [40] Standard approaches to relapsed indolent non-Hodgkin's lymphoma
    Witzig, Thomas E.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S12 - S17
12345